Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119996252 | 11999625 | 2 | F | 20050812 | 20160825 | 20160204 | 20160825 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2005-000071 | BRISTOL MYERS SQUIBB | 0.00 | Y | 0.71000 | KG | 20160825 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119996252 | 11999625 | 1 | PS | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Transplacental | 1000 MG, TID | U | 20357 | 1000 | MG | FILM-COATED TABLET | TID | |||||
| 119996252 | 11999625 | 2 | SS | AVANDIA | ROSIGLITAZONE MALEATE | 1 | Transplacental | 8 MG, QD | U | 0 | 8 | MG | QD | ||||||
| 119996252 | 11999625 | 3 | SS | FORTZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Transplacental | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 119996252 | 11999625 | 4 | SS | DAONIL | GLYBURIDE | 1 | Transplacental | 15 MG, QD | U | 0 | 15 | MG | QD | ||||||
| 119996252 | 11999625 | 5 | SS | LOXEN | NICARDIPINE HYDROCHLORIDE | 1 | Transplacental | 50 MG, BID | U | 0 | 50 | MG | BID | ||||||
| 119996252 | 11999625 | 6 | SS | ACTRAPID | INSULIN HUMAN | 1 | Transplacental | UNK | U | 0 | |||||||||
| 119996252 | 11999625 | 7 | SS | MIXTARD INSULIN | INSULIN HUMAN | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119996252 | 11999625 | 1 | Product used for unknown indication |
| 119996252 | 11999625 | 2 | Product used for unknown indication |
| 119996252 | 11999625 | 3 | Product used for unknown indication |
| 119996252 | 11999625 | 4 | Product used for unknown indication |
| 119996252 | 11999625 | 5 | Product used for unknown indication |
| 119996252 | 11999625 | 6 | Product used for unknown indication |
| 119996252 | 11999625 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119996252 | 11999625 | OT |
| 119996252 | 11999625 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119996252 | 11999625 | Congenital hydrocephalus | |
| 119996252 | 11999625 | Foetal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119996252 | 11999625 | 1 | 20050603 | 0 | ||
| 119996252 | 11999625 | 2 | 20050603 | 0 | ||
| 119996252 | 11999625 | 3 | 20050603 | 0 | ||
| 119996252 | 11999625 | 4 | 20050603 | 0 | ||
| 119996252 | 11999625 | 5 | 20050603 | 0 | ||
| 119996252 | 11999625 | 6 | 20050603 | 0 | ||
| 119996252 | 11999625 | 7 | 20050603 | 0 |